Health
COVID-19 virus could attack cancer cells and shrink tumors, new study suggests
COVID-19 can cause a long list of health issues, including flu symptoms, respiratory problems and even organ damage, according to medical experts — but a new study suggests that the virus could have a surprising impact on cancer.
The study, which was published in the Journal of Clinical Investigation on Friday, found that COVID infection was linked to cancer regression, which could serve as a foundation for new cancer treatments in the future.
The SARS-CoV-2 virus — which causes COVID — is made up of RNA (ribonucleic acid), a molecule that is found in all living cells.
VACCINES FOR FLU AND COVID: SHOULD YOU GET BOTH AT THE SAME TIME?
In the study, RNA was found to “trigger the development of a unique type of immune cell with anti-cancer properties,” according to a press release from the Northwestern Medicine Canning Thoracic Institute in Chicago.
The newly created immune cells were able to move into the blood vessels and tumors — something typical immune cells cannot do.
“These killer cells then swarm the tumor and start attacking the cancer cells directly, helping to shrink the tumor,” noted senior author Ankit Bharat, MD, chief of thoracic surgery at Northwestern Medicine, in the release.
BREAST CANCER VACCINE UPDATE FROM CLEVELAND CLINIC: ‘A NEW ERA’
This effect was activated by severe COVID-19, the researchers found, and was specifically seen to be effective against melanoma, lung cancer, breast cancer and colon cancer.
“This discovery opens up a new avenue for cancer treatment,” Bharat said in the release.
“It offers hope that we might be able to use this approach to benefit patients with advanced cancers who have not responded to other treatments.”
Early findings warrant more research
This finding has so far only been seen in animal models.
“We are in the early stages, but the potential to transform cancer treatment is there,” Bharat said in the release.
“Our next steps will involve clinical trials to see if we can safely and effectively use these findings to help cancer patients.”
“The presumed mechanism is that a major inflammation event like an infection can tip the scales toward activating the immune system against a cancer.”
Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and senior medical analyst for Fox News, pointed out that while this is “not a cancer cure and was only seen in mice,” the study does have some significance.
“It reminds us that viruses cause inflammation and rev up the immune system, which can either increase your risk of certain cancers or, paradoxically, cause certain cancers to shrink by activating immune cells against them,” Siegel, who was not involved in the study, told Fox News Digital.
Dr. Jacob Glanville, CEO of Centivax, a San Francisco biotechnology company, also was not involved in the study but said he wasn’t surprised by the findings.
“There’s a known history of this phenomenon of ‘spontaneous regression’ following an infection with a high fever in multiple illnesses, dating back as far as doctors have been identifying cancer,” he told Fox News Digital.
“Normally, the immune system can tell there’s something wrong with cancerous tissue, but cancers develop various mutations to hold the immune system back from attacking them,” Glanville went on.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“The presumed mechanism is that a major inflammation event like an infection can tip the scales toward activating the immune system against cancer.”
Studies have shown that COVID-19 vaccines could have the same effect, he added, but it’s likely more common for an actual infection to cause this, as the immune system is more “riled up” by the infection.
Even so, Glanville added, “The rate of this happening likely isn’t yet high enough to justify it as a reliable therapy.”
For more Health articles, visit www.foxnews.com/health
The study was funded by the National Institutes of Health and Canning Thoracic Institute.
Fox News Digital reached out to the researchers for additional comment.
Health
Scientists May Be Able to Make Grapefruits Compatible With Medications They Currently Interfere With
You may be among the millions of people who have seen a surprisingly specific warning like this on the labels of drugs you take:
Avoid eating grapefruit or drinking grapefruit juice while using this medication.
Such warnings are issued for dozens of substances, including docetaxel, a cancer drug; erythromycin, an antibiotic; and some statins, the cholesterol-lowering drugs prescribed to more than a third of American adults over 40.
The problem is a set of molecules, furanocoumarins. High levels of furanocoumarins interfere with human liver enzymes, among other processes. In their presence, medications can build up to unhealthy levels in the body. And grapefruits and some related citrus fruits are full of them.
But there is no such warning for other kinds of citrus, such as mandarins and other oranges. Citrus researchers at the Volcani Center in Israel reported Wednesday in the journal The New Phytologist that, by crossing mandarins and grapefruit, they’ve uncovered genes that produce furanocoumarins in some citrus fruits. It’s a finding that opens the possibility of creating grapefruit that doesn’t require a warning label.
Scientists had worked out the compounds’ structures and pieced together a basic flowchart of how they are made years ago, said Yoram Eyal, a professor at the Volcani Center. But the precise identities of enzymes catalyzing the process — the proteins that snip off a branch here, or add a piece there — remained mysterious. He and his colleagues knew that one way to identify them was to breed citrus high in furanocoumarins with those without. If the offspring of such a cross had varying levels of the substances, it should be possible, by digging into their genetics, to pinpoint the genes for the proteins.
“We were afraid to approach it, because it’s very time-consuming and it takes many years,” he said, noting how involved it can be to grow new trees from seeds and assess their genetics. “But finally, we decided we have to dive in.”
When they examined the offspring of a mandarin and a grapefruit, the researchers saw something remarkable. Fifty percent of the young plants had high levels of furanocourmains, and 50 percent had none. That particular signature meant something very specific, in terms of how the ability to make these substances is inherited.
“We saw there was only one gene that could have controlled it,” said Livnat Goldenberg, a Volcani Center researcher who is the lead author of the new study.
The researchers soon identified the gene controlling the production of furanocoumarins in leaves and fruit, which produces an enzyme called 2-oxoglutarate-dependent dioxygenase, or 2OGD for short. Mandarins, it turns out, have a mutated form of this gene that keeps the enzyme from functioning properly. This version cropped up in all the mandarin and orange varieties the researchers checked, explaining why they do not cause the same problems as grapefruit in people taking prescription medications. In these plants, furanocoumarin production is paused.
With gene editing technology, it should be possible to alter the gene in grapefruit as well, Dr. Eyal suggests. The team at the Volcani Center is now exploring that project.
Looking at how widespread this mutated version is in mandarins and some other citrus, the scientists speculate that some gene nearby on the genome must play an important role in a highly prized trait. A long-ago citrus breeder, selecting for some unknown quality, must have unwittingly spread this furanocoumarin-busting version of the gene to an ancestor of modern varieties of mandarins and oranges.
All these years later, that person’s work is coming to light, under the gaze of geneticists, who may, someday, put grapefruit back on the menu.
Health
‘Rabbit fever’ cases rising in US as CDC warns of zoonotic bacterial disease
Cases of tularemia, also known as “rabbit fever,” are on the rise in the U.S., according to a new report from the Centers for Disease Control and Prevention (CDC).
Caused by the bacteria Francisella tularensis, the disease commonly infects rabbits, hares and rodents. However, it is zoonotic, which means it can spread from animals to humans.
The bacteria is a “tier-1 select agent,” a classification given to agents and toxins that “present the greatest risk of deliberate misuse with significant potential for mass casualties or devastating effects to the economy, critical infrastructure or public confidence, and pose a severe threat to public health and safety,” per the CDC.
SUPERBUGS DUE TO ANTIBIOTIC RESISTANCE COULD KILL 39 MILLION PEOPLE BY 2050, LARGE STUDY FINDS
Although tularemia is relatively rare, with only 2,462 diagnoses between 2011 and 2022, cases have risen 56% compared to the prior decade (2001 to 2010), as reported in the CDC’s Morbidity and Mortality Weekly Report.
“Increased reporting of probable cases might be associated with an actual increase in human infection, improved tularemia detection or both,” the report states.
Health
Diabetes, heart disease cases skyrocket — and scientists pinpoint one key reason
Millions of new cases of diabetes and heart disease every year are caused by sugary drinks, according to newly published research.
Tufts University in Boston led the study, which found that about 2.2 million new diagnoses of type 2 diabetes and 1.2 million new cases of cardiovascular disease were attributed to sugar-sweetened sodas and juices each year, according to a press release.
The findings were published in the journal Nature Medicine this week.
HEART ATTACK RISK COULD RISE WITH ARTIFICIAL SWEETENER CONSUMPTION, STUDY FINDS
The highest rates were found in Colombia, where 48% of new diabetes cases were linked to sugary drinks, and in Mexico, where nearly a third of cases were attributed to them.
Meanwhile, in Latin America, more than 24% of new diabetes cases were linked to sugary beverages, and 21% in sub-Saharan Africa, the study found.
In South Africa, 27.6% of new diabetes cases and 14.6% of cardiovascular disease cases were attributed to sugary drinks.
Sugary drinks are rapidly digested, causing a spike in blood sugar levels with little nutritional value.
Sugary drinks cause blood sugar to spike because they are “rapidly digested,” the research team said.
When consumed on a long-term basis, these types of beverages, in addition to increasing the risk of type 2 diabetes and heart disease, can also lead to weight gain and insulin resistance, the researchers added.
Professor Dariush Mozaffarian, the study’s senior author, said in a university press release, “Sugar-sweetened beverages are heavily marketed and sold in low- and middle-income nations.”
He added, “Not only are these communities consuming harmful products, but they are also often less well-equipped to deal with the long-term health consequences.”
FRIENDS, FAMILY MAY PROTECT AGAINST HEART ATTACK, STROKE AND TYPE 2 DIABETES, STUDY SUGGESTS
Certain groups are more likely to experience negative health effects from sugary drinks, including men and younger adults, the researchers noted, as news agency SWNS also noted.
New Jersey-based registered dietitian Erin Palinski-Wade, who was not involved in the research, said the findings were to be expected, as diets rich in added sugars are more likely to increase the risk of chronic health conditions, including type 2 diabetes.
“Sugar-sweetened beverages are a major cause of added sugar in the diet and easy to overconsume, as they provide little fullness,” she told Fox News Digital.
“The high calorie content and lack of satisfaction due to little protein, fat or fiber in these drinks can lead to excess calorie consumption, which can lead to weight gain — especially gains in visceral fat (belly fat), which has been found to increase the risk of type 2 diabetes,” she went on.
“Sugar-sweetened beverages are easy to overconsume, as they provide little fullness.”
Palinski-Wade pointed out that there were some limitations to the new research.
“This was an observational study, not a causation study, and shows only an association between diets containing sugar-sweetened beverages and diabetes,” she noted.
“It does not prove that those drinks alone trigger an onset of type 2 diabetes.”
What needs to change?
To remedy the issue, the study authors called for a “multi-pronged approach,” including public health campaigns, regulations on advertising and taxes on sugar-sweetened beverages, the release stated.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“We need urgent, evidence-based interventions to curb consumption of sugar-sweetened beverages globally, before even more lives are shortened by their effects on diabetes and heart disease,” first author Laura Lara-Castor, now at the University of Washington, said in the release.
Mexico implemented a sugary drinks tax in 2014, which has shown to be effective in reducing consumption, the researchers stated.
“Much more needs to be done, especially in countries in Latin America and Africa, where consumption is high and the health consequences severe,” wrote Mozaffarian.
For more Health articles, visit www.foxnews.com/health
“As a species, we need to address sugar-sweetened beverage consumption.”
Many different factors are involved in insulin resistance and type 2 diabetes, Palinski-Wade noted.
“As a species, we need to address sugar-sweetened beverage consumption.”
“However, reducing your intake of sugar-sweetened beverages can go a long way toward improving overall blood sugar regulation and future health.”
The new research was supported by the Gates Foundation, the American Heart Association and Mexico’s National Council for Science and Technology.
Fox News Digital reached out to the researchers for further comment.
-
Business1 week ago
These are the top 7 issues facing the struggling restaurant industry in 2025
-
Culture1 week ago
The 25 worst losses in college football history, including Baylor’s 2024 entry at Colorado
-
Sports1 week ago
The top out-of-contract players available as free transfers: Kimmich, De Bruyne, Van Dijk…
-
Politics1 week ago
New Orleans attacker had 'remote detonator' for explosives in French Quarter, Biden says
-
Politics1 week ago
Carter's judicial picks reshaped the federal bench across the country
-
Politics6 days ago
Who Are the Recipients of the Presidential Medal of Freedom?
-
Health5 days ago
Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
-
World1 week ago
Ivory Coast says French troops to leave country after decades